T he goal of the Research Committee is to build, in collaboration with the Canadian Institutes of Health Research (CIHR) and the Canadian Association of Gastroenterology (CAG) partners, Canadian capacity and expertise in the discipline of gastroenterology and nutrition, and to promote excellence in research. As chair of the CAG Research Committee, it is my privilege to update the CAG membership and The Canadian Journal of Gastroenterology readership on the activities of the CAG Research Committee (2003) (2004) , in what has been yet another outstanding year for investment in gastrointestinal (GI) research in Canada.
First, I gratefully acknowledge the efforts of the Research Committee (Table 1) , Mr Paul Sinclair, the CAG National Executive Director, and Ms Sandra Daniels, Manager of CAG, for their participation in, and commitment to, the research activities of the CAG. They all make my 'job' much easier. I take this opportunity to thank Drs A Buchan (University of British Columbia), JF Beaulieu (Sherbrooke University), K Chadee (McGill University) and W Paterson (Queen's University) who completed their terms as committee members (2000) (2001) (2002) (2003) , and to welcome Drs Alison FoxRobichaud, Linda Rabeneck, Natalie Rivard and Andre Buret as new committee members effective February 2004.
Details relating to eligibility and application processes for all of the following awards are available at the CAG Web site <www.cag-acg.org>. The review and assessment of applications complies with CIHR standards and guidelines.
Operating grants
The Canadian Digestive Health Foundation (CDHF)/CAG New Investigator Grant in partnership with ALTANA Pharma Inc and the CIHR was awarded to Mark Ropeleski (MD) (Queen's University) for a project relating to IL-11 signalling in gut epithelium. The CDHF/CAG Operating Grant, in partnership with Abbott Laboratories Ltd and CIHR, went to Herbert Giasano (MD, PhD) (University of Toronto) to assess SNARE protein involvement in muscle contractility. Five applications were reviewed in each grant competition.
Fellow-to-Faculty Transition Award
Two fellows received bridge funding to facilitate a move into full-time faculty Assistant Professorships (Table 2) . Dr Emma Ambrose (PhD) will examine the role of gut pathogens in inflammatory bowel disease and bacterial-epithelial interactions, and Dr Kevin Rioux (PhD, MD) will assess the impact of acetylsalicylic acid and the normal flora in inflammatory bowel disease. Having seen this programme enter its second year and the quality of the applications it attracts, it is our hope to sustain this fledgling programme. It is a pleasure to be able to thank the Crohn's and Colitis Foundation of Canada (CCFC) and AstraZeneca Canada Inc for the continued funding of this research initiative.
CAG-CIHR-Partner Funded Post-Doctoral Operating Fellowship Programme
The fellowship programme is the hallmark of excellence in the CAG research activities. Recently, Sandra Daniels and I summarized and published an article (Can J Gastroenterol 2003;17:437-9) on the investment in and resultant productivity from the first 10 years of the fellowship programme. The data are remarkable and testify to an outstanding programme -a reflection of the value that the CAG executive and CAG partners place on this programme and the quality of the fellows who receive support. The report was further distributed to the Canadian public in an excellent insert that appeared in the December 29, 2003 issue of Maclean's and the February issue of L'actualité.
This year, 26 fellowship applications were received. With support from CIHR, the CCFC, the CDHF and the CAG's industrial partners (see acknowledgements) 14 fellowships were funded -a 54% success rate (comparable with last year's 56% success rate). Ten of 15 applications from PhD scientists were funded and four of 11 from MD scientists. Twelve of 22 male applicants were funded (ie, 55%) and two of four female applicants (50%) were successful in this competition (Table 3) .
PhD studentships
In the past year, five CAG trainee members received one-year studentships ($20,500) The CAG is proud to acknowledge its Benefactor Corporate Sponsors: Abbott Laboratories Ltd.
AstraZeneca Canada Inc. Axcan Pharma Inc. Janssen-Ortho Inc. Pfizer Canada Inc.
CAG summer studentships
It is critical that young investigators be supported at all levels of their training. Thus, in partnership with CCFC, eight students received awards (salary plus a small operating budget; $5,000/award) to work in laboratories of established investigators whose interests cover many facets of gut function (Table 4) . Twenty high quality applications were reviewed, giving a 40% success rate in this year's competition.
Resident Research Programme -A NEW INITIATIVE
We recognized that one particular constituent of the CAG membership was being overlooked -the GI resident. 
Interactions with CIHR
This year, the presidents of the CAG and the CDHF, Dr P Sherman and Dr G Levy, signed a memorandum of understanding (or collective agreement) with CIHR RxD. This document formalizes our partnership with CIHR and clearly defines the financial arrangements, review processes and policies surrounding partnered research programmes. The document is available from the CAG National Office. Basically, the document holds the CAG to CIHR review practices, standards and policies with additional criteria being added by the CAG. Stipulations are in place to allow updates and revisions to each part of the agreement and the memorandum of understanding will be reviewed in 2007. On behalf of the CAG and CDHF, myself and Dr S Vanner (Queen's University) responded to a call from Dr A Bernstein, the President of CIHR, for comments on the CIHR Blueprint, a strategic planning document. There was much of value in the Blueprint, although GI Research was not specifically mentioned. We drew this to Dr Bernstein's attention and highlighted the impact that digestive disease has on Canadians. The year ahead By any standards this has been an excellent year for highlighting Canadian GI research and everyone involved deserves congratulations. The goal for the CAG Research Committee is simply twofold: to consolidate and expand on this success. We will strive to maintain the level of excellence that already exists in our research programmes and will work to: fully establish the Fellow-to-Faculty and resident research programmes; expand the PhD studentship programme with the goal of achieving three-year awards; stimulate interactions between the GI community and other disciplines; foster closer relations with the CIHR Institute of Nutrition, Metabolism and Diabetes; and ensure that the CDDW is a first-rate gastroenterology research meeting with Canadian collegiality at the forefront. Should CAG members have questions relating to the activities of the Research Committee or proposals on how to expand or promote our activities please contact me (mckayd@mcmaster.ca) or any member of the research committee (Table 1) In addition, Dr J Brumell's name was misspelled in Table 3 of the same article. We apologize for any inconvenience this may have caused. Table 1 The Canadian Association of Gastroenterology Research Committee (2004) 
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